Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Small Firms Jeopardized By SBA Venture Cap Limit On R&D Grants – MDMA

This article was originally published in The Gray Sheet

Executive Summary

Venture capital-backed companies may be barred from obtaining NIH grants under the Small Business Administration's proposed changes to the Small Business Innovation Research program, the Medical Device Manufacturers Association warns

You may also be interested in...



SBIR Eligibility For Venture Cap Encouraged By NVCA Data Gathering Effort

The National Venture Capital Association will attempt to quantify the total number of lives saved by VC-backed technologies in a report on the role of early-stage funding in medical device innovation

EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions

It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018715

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel